ABOUT US

EffPha Maximizes Value and Minimizes Risks

Efficient Pharma Management Corp. (EffPha) provides drug development services to pharmaceutical and biotechnology companies.Our services focus on information integration for the strategic consulting, dossier preparation and submission, and efficient management of the Phase I-III clinical research to accelerate your drug development to approval. With extensive regulatory experience and multi-cultural familiarity, EffPha serves as your regional hub in Asia, and bridges the gaps between Asian and global pharmaceutical industries to widen your market reach.

Our Mission and Value

Efficient Pharma Management Corp. (EffPha) was founded in 2009 with the mission to assist pharmaceutical companies in development of new drugs by providing world-class integrated knowledge and extensive experiences. We accelerate your drug development programs by planning the right strategy, avoiding or minimizing delays in preclinical development, and assuring timely and accurate study outcomes. EffPha effectively manages every step to ensure you have a rapid, cost-effective, and quality development program.

What’s In Our Name

Expertise

We gather experts with 20+ years of drug development experience

Facilitate

We facilitate and accelerate your drug development process

Fast-growing

We have completed more than 200 projects since founded in 2009

Precision

We provide advice and knowledge that has resulted in 100% regulatory approval rate

High-quality

We follow GxP requirements and make sure the quality is satisfactory

Adaptability

We are familiar with both local and global regulatory standards, and thus are able to adapt to the fast-changing environment

We Are Your Best Partner for Drug Development

We provide efficient project management in coordinating vendors of various functions. With fast problem-solving ability, timely interaction and communication, EffPha is your best partner to help you manage your product development and ensure your studies are performed intelligently and efficiently to meet global regulatory requirements.